Immune Pharmaceuticals and The International Pemphigus & Pemphigoid Foundation (IPPF) Celebrate Rare Disease Day
SWI Editorial Staff2016-03-02T11:50:00-08:00NEW YORK, Feb. 29, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company, and the International Pemphigus & Pemphigoid Foundation (IPPF) announce support for Rare Disease ...